FY 2024 Alzheimer’s Disease and Related Dementias Bypass Budget Released
At today’s meeting of the Advisory Council on Alzheimer’s Research, Care, and Services, NIA Director Dr. Richard Hodes presented the NIH FY 2024 Professional Judgment Budget, “Looking Forward: Opportunities to Accelerate Alzheimer’s and Related Dementias Research.” For FY 2024, the content and structure of the Professional Judgment Budget, or “Alzheimer’s Disease Bypass Budget” (ADBB), have been updated. Previous ADBB narratives focused on scientific accomplishments in AD/ADRD research. The FY 2024 ADBB narrative outlines examples of prospective research opportunities that could be supported with additional funds in FY 2024. Examples of future research opportunities are organized across six broad scientific categories:
- Epidemiology/Population Studies
- Disease Mechanisms
- Diagnosis, Assessment, & Disease Monitoring
- Translational Research & Clinical Interventions
- Dementia Care & Impact of Disease
- Research Resources
The FY 2024 ADBB also emphasizes significant cross-cutting research efforts centered on health equity and inclusion. For FY 2024, additional NIH resources needed for new Alzheimer’s and related dementias research are $321 million, which would bring the total FY 2024 NIH resource needs for AD/ADRD research to $3.87 billion.
NIA’s Office of Legislation, Policy, and International Activities will hold a webinar for stakeholders on Thursday, August 11th, from 11:00 am—12:00 pm ET to review the FY 2024 ADBB and answer any questions you may have. To register, please visit the webinar registration page.
